The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...
Still, the medications in the latest round of negotiations — which now includes Part B drugs given in doctor’s offices — draw very limited revenue from Medicare, an analyst pointed out.
The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus ...